Literature DB >> 7397697

Radiolabeling of antibodies.

W C Eckelman, C H Paik, R C Reba.   

Abstract

The radiolabeling of antibodies is considered in terms of the choice of radionuclide, the method of conjugation, and the effect of conjugation on plasma clearance. Iodination techniques are reviewed, but the major emphasis is placed on the methods of conjugating metallic radionuclides using bifunctional chelating agents. The technique of producing clinically useful radiolabeled antibodies by balancing altered substrate specificity caused by radiolabeling against accelerated plasma clearance is discussed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7397697

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  8 in total

1.  Improved cancer therapy and molecular imaging with multivalent, multispecific antibodies.

Authors:  Robert M Sharkey; Edmund A Rossi; Chien-Hsing Chang; David M Goldenberg
Journal:  Cancer Biother Radiopharm       Date:  2010-02       Impact factor: 3.099

2.  Optimization of microfluidic PET tracer synthesis with Cerenkov imaging.

Authors:  Alex A Dooraghi; Pei Y Keng; Supin Chen; Muhammad R Javed; Chang-Jin C J Kim; Arion F Chatziioannou; R Michael van Dam
Journal:  Analyst       Date:  2013-10-07       Impact factor: 4.616

3.  Applicability of short-lived radiometallic nuclide for high sensitivity two-site "sandwich" immunoradiometric assay: human growth hormone assay.

Authors:  K Horiuchi; L H Lin; Y Fujibayashi; V C Borghi; A Yokoyama
Journal:  Ann Nucl Med       Date:  1996-02       Impact factor: 2.668

4.  Localisation of malignant germ-cell tumours by external scanning after injection of radiolabelled anti-alpha-fetoprotein.

Authors:  A K Halsall; D S Fairweather; A R Bradwell; J C Blackburn; P W Dykes; A Howell; A Reeder; K R Hine
Journal:  Br Med J (Clin Res Ed)       Date:  1981-10-10

Review 5.  Antitumor monoclonal antibodies for radioimmunodetection of tumors and drug targeting.

Authors:  R W Baldwin; M V Pimm
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

6.  Improved tumour localisation using indium-111 labelled antibodies.

Authors:  D S Fairweather; A R Bradwell; P W Dykes; A T Vaughan; S F Watson-James; S Chandler
Journal:  Br Med J (Clin Res Ed)       Date:  1983-07-16

7.  Immunoreactivity of monoclonal anti-melanoma antibodies in relation to the amount of radioactive iodine substituted to the antibody molecule.

Authors:  S Matzku; H Kirchgessner; W G Dippold; J Brüggen
Journal:  Eur J Nucl Med       Date:  1985

8.  A Novel Antibody-IL15 Fusion Protein Selectively Localizes to Tumors, Synergizes with TNF-based Immunocytokine, and Inhibits Metastasis.

Authors:  Riccardo Corbellari; Marco Stringhini; Jaqueline Mock; Tiziano Ongaro; Alessandra Villa; Dario Neri; Roberto De Luca
Journal:  Mol Cancer Ther       Date:  2021-02-25       Impact factor: 6.261

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.